Plus   Neg

Nasal Spray Treatment For Migraines Shows Promise


A new migraine treatment that delivers painkillers via nasal spray is showing promise for migraine sufferers, according to a new study from researchers at the Albany Medical Center, in Albany, New York. The new treatment sends a dose of the anesthetic lidocaine (Xylocaine) directly to the nerves at the rear of the nasal cavity.

Get ahead of the stock market. For in-depth analysis not available anywhere else, check out RTTNews' premium research products.

According to researchers, those who have had the procedure reported a drop in symptoms of roughly 35 percent for about one month. Peer reviewer Dr. Richard Lipton, director of the Montefiore Headache Center in New York City said the progress is exciting.

"Unmet treatment needs in chronic migraine are huge, as is the overuse of medications," Lipton noted. "When a body gets used to having a chronic headache suppressor, the patient can experience a rebound in the absence of that suppressor. So developing an effective treatment that can reduce the need for acute medicine would be very valuable."

He adds, "These results sound very promising. Of course, it remains to be seen if the demonstrated benefit already seen holds up over a longer period of time, and with a bigger group of patients."

For comments and feedback contact: editorial@rttnews.com

Health News

Follow RTT